precision oncology
No description yet: the sentence for this tag has not been written. 8 records carry it: 8 people. Also written “precision-oncology”; the spellings share this page.
Related tags
8 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Christian Brandts Director, UCT Frankfurt (Geschäftsführender Direktor) · University Cancer Center Frankfurt (UCT) Haematologist-oncologist who is Managing Director of the University Cancer Center Frankfurt. | Acute myeloid leukaemia | none | leadership, clinician-scientist, haematology | ||
Hanno Glimm Managing Director (Geschäftsführender Direktor); Head, Department of Translational Medical Oncology · NCT/UCC Dresden, University Hospital Carl Gustav Carus Medical oncologist who co-directs NCT/UCC Dresden and co-leads the NCT/DKFZ MASTER precision oncology programme for rare and young-onset cancers. | none | none | leadership, clinician-scientist, cancer genomics | ||
Kjetil Taskén Head of the Institute for Cancer Research · Oslo University Hospital, The Norwegian Radium Hospital Immunologist and head of the Institute for Cancer Research at Oslo University Hospital's Norwegian Radium Hospital, leading Norway's largest cancer research institute. | none | none | leadership, clinician-scientist, immunology | ||
Michael F. Berger Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center · Memorial Sloan Kettering Cancer Center Built MSK-IMPACT, the tumour sequencing test used on more than 100,000 patients and the first FDA-authorised hospital panel. | none | none | genomics, diagnostics | ||
Razelle Kurzrock Professor of Medicine, Medical College of Wisconsin; Linda T. and John A. Mellowes Endowed Chair in Precision Oncology · Medical College of Wisconsin Cancer Center Precision oncology pioneer who showed that matching drugs to each patient's mutations, in combination, improves outcomes. | none | none | early-phase, n-of-1 | ||
Shivaani Kummar Chief Scientific and Academic Officer, Knight Cancer Group and Director, Knight Cancer Institute · OHSU Knight Cancer Institute Drug development oncologist who directs the OHSU Knight Cancer Institute. | none | none | leadership, clinician-scientist, drug development | ||
Takayuki Yoshino Chief, Department of Gastroenterology and GI Oncology, National Cancer Center Hospital East; President, Japanese Society of Medical Oncology · National Cancer Center Hospital Leads CIRCULATE-Japan, the largest ctDNA-guided adjuvant programme in colorectal cancer, and the PARADIGM and SCRUM-Japan GI efforts. | Colorectal cancer, Gastric & gastro-oesophageal junction cancer | none | leadership, clinician-scientist, colorectal cancer | ||
Tony S. K. Mok Chairman, Department of Clinical Oncology; Li Shu Fan Professor of Clinical Oncology · Prince of Wales Hospital / Chinese University of Hong Kong Lung cancer pioneer whose IPASS trial established EGFR-targeted therapy as first-line treatment; chairs Clinical Oncology at CUHK. | Non-small-cell lung cancer | none | leadership, clinician-scientist, lung cancer |